Press Releases
Washington, D.C. — Congressman Matt Gaetz (FL-01) today issued the following statement applauding the U.S. Food and Drug Administration (FDA) for approving the first prescription drug derived from the cannabis plant, as a treatment for specific forms of epilepsy.
Washington, D.C. — U.S. Congressman Matt Gaetz (FL-01) issued the following statement today after voting for the House Budget Committee’s FY19 budget resolution, which was referred favorably to the House by a vote of 21–13:
Washington, D.C. — Congressman Matt Gaetz (FL-01) today issued the following statement after voting against H.R. 6, the SUPPORT for Patients and Communities Act:
Washington, D.C. — U.S. Congressman Matt Gaetz (FL-01) issued the following statement today after voting in favor of H.R. 4760, the Securing America's Future Act, which was defeated in the House by a vote of 193–231:
Washington, D.C. — U.S. Congressman Matt Gaetz (FL-01) today issued the following statement in response to President Donald Trump’s executive order (EO) addressing family separation at the U.S. border.
PENSACOLA, FL – On Monday, June 18, 2018, Congressman Matt Gaetz hosted a roundtable discussion with several industries in the field of technology, government and community leaders to cultivate ideas for Pensacola to become a "smart city" serving as a hub for 5G Beta testing. This venture is the beginning in a series of discussions to kickstart Northwest Florida's evolution to emerge as a lead
Washington, D.C. — Congressman Matt Gaetz (FL-01) today issued the following statement after voting against H.R. 5327, the Comprehensive Opioid Recovery Centers Act, sponsored by Rep. Brett Guthrie (KY-02):
Washington, D.C. — U.S. Congressman Matt Gaetz (FL-01) today issued the following statement prior to attending the posthumous promotion ceremony of Air Force Colonel George “Bud” Day to the rank of Brigadier General. The ceremony honoring Colonel Day will commence later this evening at the Air Force Memorial in Arlington, Virginia.